Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Epigenetic-modification associated hnRNPA3 acts as a prognostic biomarker and promotes malignant progression of HCC

Fig. 6

Spatial transcriptomics analysis revealing hnRNPA3 in LIHC. A, B, C, D Expression and localization of 12 types of immune-related cells, hnRNPA3, and malignant cells in P8T. E, F, G, H Expression and localization of 12 types of immune-related cells, hnRNPA3, and malignant cells in P9T. I The correlation between hnRNPA3 and the content of 12 types of immune cells in P8T. J The difference of hnRNPA3 between the malignant cell group (Mal) and the non-malignant cell group (nMal) in P8T. K The correlation between hnRNPA3 and the content of 12 types of immune cells in P9T. L The difference of hnRNPA3 between the malignant cell group (Mal) and the non-malignant cell group (nMal) in P9T

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us